StephenC.LazarusMD
Pulmonology • San Francisco, CAAsthma & COPD, Critical Care Medicine, Pleural Disease
Professor, Medicine, UCSF School of Medicine
Dr. Lazarus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Ave
1087 M
San Francisco, CA 94143Phone+1 415-353-2961Fax+1 415-476-5712- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1975 - 1977- University of California (San Francisco)Residency, Internal Medicine, 1973 - 1975
- University of California (San Francisco)Internship, Internal Medicine, 1972 - 1973
University of California, Irvine, School of MedicineClass of 1972
Certifications & Licensure
CA State Medical License 1973 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease Start of enrollment: 2005 Mar 01
- Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease Start of enrollment: 2006 Mar 01
- Simvastatin Therapy for Moderate and Severe COPD Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsLongitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.William McKleroy, Tracie Shing, Wayne H Anderson, Mehrdad Arjomandi, Hira Anees Awan, Igor Barjaktarevic, R Graham Barr, Eugene R Bleecker, John Boscardin, Russell P B...> ;JAMA. 2023 Aug 1
- 26 citationsBronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.MeiLan K Han, Wen Ye, Di Wang, Emily White, Mehrdad Arjomandi, Igor Z Barjaktarevic, Stacey-Ann Brown, Russell G Buhr, Alejandro P Comellas, Christopher B Cooper, Gera...> ;The New England Journal of Medicine. 2022 Sep 29
- 4 citationsClinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical Trial.Robert A Wise, Janet T Holbrook, Robert H Brown, Gerard J Criner, Mark T Dransfield, Jiaxian He, Robert J Henderson, David A Kaminsky, Robert J Kaner, Stephen C Lazaru...> ;American Journal of Respiratory and Critical Care Medicine. 2022 Oct 1
- Join now to see all
Press Mentions
Mometasone, Tiotropium Show No Preferred Asthma Benefit in SIENA TrialMay 19th, 2019
Eosinophil Levels Affect Glucocorticoid Response in Mild, Persistent AsthmaMay 19th, 2019
Lansoprazole for Children with Poorly Controlled AsthmaA Randomized Controlled TrialJanuary 25th, 2012
Grant Support
- SPIROMICSNational Heart, Lung & Blood Institute2009–Present
- AsthmaNetNational Heart, Lung & Blood Institute2009–Present
- COPD Clinical ResearchNetworkNational Heart, Lung & Blood Institute2006–Present
- Asthma Clinical Research NetworkNational Heart, Lung & Blood Institute2003–2011
- COPD Clinical Research NetworkNational Heart, Lung, And Blood Institute2003–2006
- Non-Immunologic Contact Urticaria And MAST CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1989
- Non-Immunologic Contact Urticaria &Mast CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1987–1988
- Regulation Of Tracheal Secretory Cells: Role Of CAMPNational Heart, Lung, And Blood Institute1985
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
